Insider Trading activities of Acelrx Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acelrx Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Acelrx Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Acelrx Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is ACRX. The reporting company's CIK number is 1427925.
The total value of stock buying since 2005 is $51,904,290.
The total value of stock sales since 2005 is $22,456,114.
The total value of stock option exercises since 2005 is $152,240.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Acelrx Pharmaceuticals Inc (ACRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 35,000 $66,680 0 $0 0 $0
2017-10 0 $0 10,161 $53,751 37,500 $45,000
2017-09 7,000 $22,708 13,827 $0 0 $0
2017-08 30,000 $89,590 0 $0 0 $0
2017-06 0 $0 875,000 $2,100,000 0 $0
2016-09 0 $0 609,350 $2,294,466 0 $0
2016-05 25,206 $80,521 0 $0 0 $0
2015-11 0 $0 268,300 $1,366,214 0 $0
2015-09 0 $0 310,000 $1,294,869 0 $0
2015-08 0 $0 0 $0 29,000 $74,240
2015-05 75,400 $125,120 0 $0 0 $0
2015-03 0 $0 0 $0 25,000 $33,000
2014-06 1,000 $10,300 0 $0 0 $0
2014-03 0 $0 1,000,000 $12,329,370 0 $0
2013-11 515,660 $3,516,577 0 $0 0 $0
2013-10 200,000 $1,338,600 0 $0 0 $0
2013-09 0 $0 286,933 $3,017,444 0 $0
2013-07 850,000 $9,902,500 0 $0 0 $0
2013-06 10,000 $81,000 0 $0 0 $0
2013-05 75,000 $614,000 0 $0 0 $0
2012-12 2,416,918 $7,999,998 0 $0 0 $0
2012-05 569,396 $1,935,946 0 $0 0 $0
2011-12 10,000 $27,900 0 $0 0 $0
2011-11 40,000 $116,000 0 $0 0 $0
2011-09 10,000 $33,419 0 $0 0 $0
2011-08 3,000 $9,294 0 $0 0 $0
2011-06 12,300 $56,527 0 $0 0 $0
2011-02 5,175,522 $25,877,610 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Acelrx Pharmaceuticals Inc insiders (ACRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-14 Edwards Mark G (Director) Buy 30,000 1.90 56,970
2017-11-13 Asadorian Raffi (Chief Financial Officer) Buy 5,000 1.94 9,710
2017-10-19 Dasu Badri N (Chief Engineering Officer) Option Ex 37,500 1.20 45,000
2017-10-02 Hamel Lawrence G (Chief Development Officer) Sale 10,161 5.29 53,751
2017-09-25 Hamel Lawrence G (Chief Development Officer) Sale 13,827 .00 0
2017-09-11 Asadorian Raffi (Chief Financial Officer) Buy 7,000 3.24 22,708
2017-08-24 Angotti Vincent J. (Chief Executive Officer) Buy 15,000 3.00 45,000
2017-08-24 Edwards Mark G (Director) Buy 4,800 3.02 14,520
2017-08-22 Palmer Pamela P (Chief Medical Officer) Buy 10,000 2.95 29,490
2017-08-22 Edwards Mark G (Director) Buy 200 2.90 580
2017-06-19 Edelman Joseph (10% Owner) Sale 875,000 2.40 2,100,000
2016-09-29 Perceptive Life Sciences Master Fund Ltd Sale 97,200 3.88 377,136
2016-09-28 Perceptive Life Sciences Master Fund Ltd Sale 119,300 3.96 472,428
2016-09-15 Perceptive Life Sciences Master Fund Ltd Sale 392,850 3.68 1,444,902
2016-05-13 Rosen Howard B (CEO) Buy 10,206 3.26 33,271
2016-05-12 Edwards Mark G (Director) Buy 5,000 3.05 15,250
2016-05-11 Edwards Mark G (Director) Buy 5,000 3.15 15,750
2016-05-10 Edwards Mark G (Director) Buy 5,000 3.25 16,250
2015-11-18 Perceptive Life Sciences Master Fund Ltd Sale 42,300 5.35 226,135
2015-11-17 Perceptive Life Sciences Master Fund Ltd Sale 133,900 5.36 717,436
2015-11-06 Perceptive Life Sciences Master Fund Ltd Sale 17,100 4.47 76,368
2015-11-05 Perceptive Life Sciences Master Fund Ltd Sale 75,000 4.62 346,275
2015-09-09 Perceptive Life Sciences Master Fund Ltd Sale 310,000 4.18 1,294,869
2015-08-20 Palmer Pamela P (Chief Medical Officer) Option Ex 29,000 2.56 74,240
2015-05-19 Rosen Howard B (Intermin CEO) Buy 35,400 .00 0
2015-05-07 Edwards Mark G (Director) Buy 40,000 3.13 125,120
2015-03-12 Palmer Pamela P (Chief Medical Officer) Option Ex 25,000 1.32 33,000
2014-06-23 Afable Richard (Director) Buy 1,000 10.30 10,300
2014-03-10 Wan Mark A (Director) Sale 835,327 12.36 10,324,641
2014-03-07 Wan Mark A (Director) Sale 164,673 12.17 2,004,729
2013-11-07 Perceptive Life Sciences Master Fund Ltd Buy 100,000 6.50 649,800
2013-11-06 Perceptive Life Sciences Master Fund Ltd Buy 100,000 6.52 651,700
2013-11-04 Perceptive Life Sciences Master Fund Ltd Buy 155,000 6.86 1,063,145
2013-11-01 Perceptive Life Sciences Master Fund Ltd Buy 160,660 7.17 1,151,932
2013-10-31 Perceptive Life Sciences Master Fund Ltd Buy 200,000 6.69 1,338,600
2013-09-20 Nohra Guy P (Director) Sale 96,519 10.84 1,046,169
2013-09-19 Nohra Guy P (Director) Sale 61,634 10.21 629,468
2013-09-18 Nohra Guy P (Director) Sale 62,461 10.29 642,473
2013-09-17 Nohra Guy P (Director) Sale 49,921 10.48 523,122
2013-09-16 Nohra Guy P (Director) Sale 16,398 10.75 176,212
2013-07-23 Perceptive Life Sciences Master Fund Ltd Buy 850,000 11.65 9,902,500
2013-06-06 Edwards Mark G (Director) Buy 10,000 8.10 81,000
2013-05-28 Adams Adrian (Director) Buy 50,000 8.39 419,500
2013-05-24 Adams Adrian (Director) Buy 25,000 7.78 194,500
2012-12-07 Three Arch Associates Iv Lp (10% Owner) Buy 2,416,918 3.31 7,999,998
2012-05-29 Freund John Gordon (10% Owner) Buy 284,698 3.40 967,973
2012-05-29 Three Arch Associates L P (10% Owner) Buy 284,698 3.40 967,973
2011-12-01 Edwards Mark G (Director) Buy 10,000 2.79 27,900
2011-11-14 Edwards Mark G (Director) Buy 40,000 2.90 116,000
2011-09-07 Welch James H (Chief Financial Officer) Buy 3,000 3.39 10,179
2011-09-06 Welch James H (Chief Financial Officer) Buy 7,000 3.32 23,240
2011-08-29 Schreck Thomas A (Director) Buy 1,000 3.27 3,274
2011-08-24 Schreck Thomas A (Director) Buy 2,000 3.01 6,020
2011-06-09 Palmer Pamela P (Chief Medical Officer) Buy 8,800 4.61 40,568
2011-06-09 King Richard (Chief Executive Officer) Buy 3,500 4.56 15,959
2011-02-16 Freund John Gordon (10% Owner) Buy 1,235,943 5.00 6,179,715
2011-02-16 Acmp Iv Llc (10% Owner) Buy 680,000 5.00 3,400,000
2011-02-16 Three Arch Partners Iv Lp (10% Owner) Buy 1,289,790 5.00 6,448,950
2011-02-16 Nohra Guy P (Director) Buy 680,000 5.00 3,400,000
2011-02-16 Three Arch Associates Iii Lp (10% Owner) Buy 1,289,789 5.00 6,448,945

Insider trading activities including stock purchases, stock sales, and option exercises of ACRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Acelrx Pharmaceuticals Inc (symbol ACRX, CIK number 1427925) see the Securities and Exchange Commission (SEC) website.